Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

John H Rees,Torge Rempe,Ibrahim Sacit Tuna,Mayra Montalvo Perero,Shyamsunder Sabat,Tara Massini,Joseph M Yetto,John H. Rees,Joseph M. Yetto

DOI: https://doi.org/10.1016/j.mric.2023.12.001

IF: 1.376

2024-02-01

Magnetic Resonance Imaging Clinics of North America

Abstract:For over two centuries, clinicians have been aware of various conditions affecting white matter which had come to be grouped under the umbrella term multiple sclerosis. Within the last 20 years, specific scientific advances have occurred leading to more accurate diagnosis and differentiation of several of these conditions including, neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody disease. This new understanding has been coupled with advances in disease-modifying therapies which must be accurately applied for maximum safety and efficacy.

radiology, nuclear medicine & medical imaging